Royce & Associates LP boosted its holdings in Masimo Co. (NASDAQ:MASI) by 6.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 124,600 shares of the medical equipment provider’s stock after acquiring an additional 7,000 shares during the quarter. Royce & Associates LP owned 0.24% of Masimo worth $10,785,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. BlackRock Inc. lifted its position in Masimo by 7.5% in the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after acquiring an additional 550,995 shares in the last quarter. Vanguard Group Inc. lifted its position in Masimo by 6.9% in the 2nd quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock valued at $450,036,000 after acquiring an additional 318,060 shares in the last quarter. State Street Corp lifted its position in Masimo by 10.4% in the 2nd quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock valued at $141,121,000 after acquiring an additional 146,212 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its position in Masimo by 3.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,113,113 shares of the medical equipment provider’s stock valued at $101,494,000 after acquiring an additional 38,991 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its position in Masimo by 27.1% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after acquiring an additional 233,412 shares in the last quarter. 83.74% of the stock is currently owned by institutional investors and hedge funds.
Shares of Masimo Co. (MASI) opened at $85.98 on Thursday. The company has a market cap of $4,417.88, a PE ratio of 32.76, a price-to-earnings-growth ratio of 2.88 and a beta of 0.72. Masimo Co. has a one year low of $64.29 and a one year high of $104.71.
Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.17. The firm had revenue of $193.69 million during the quarter, compared to analyst estimates of $189.01 million. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The company’s revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter last year, the business posted $0.52 EPS. analysts expect that Masimo Co. will post 2.95 earnings per share for the current year.
MASI has been the topic of several recent research reports. Zacks Investment Research raised shares of Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a research report on Thursday, November 2nd. Stifel Nicolaus reaffirmed a “buy” rating and issued a $108.00 price target on shares of Masimo in a research report on Friday, November 3rd. Finally, BidaskClub cut shares of Masimo from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $97.17.
In other Masimo news, EVP Yongsam Lee sold 18,198 shares of the stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $88.85, for a total value of $1,616,892.30. Following the completion of the sale, the executive vice president now owns 70,800 shares in the company, valued at approximately $6,290,580. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Steven Barker sold 10,000 shares of the stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total transaction of $900,000.00. Following the completion of the sale, the director now owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The disclosure for this sale can be found here. In the last quarter, insiders sold 53,074 shares of company stock valued at $4,737,245. Company insiders own 13.10% of the company’s stock.
WARNING: This report was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://ledgergazette.com/2017/12/14/masimo-co-masi-shares-bought-by-royce-associates-lp.html.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.